Ferumoxytol Use as an Intravenous Contrast Agent for Magnetic Resonance Angiography

MRI Using Ferumoxytol Improves the Visualization of Central Nervous System Vascular Malformations

(2011) Edit Dósa et al.   STROKE

Potential for Differentiation of Pseudoprogression From True Tumor Progression With Dynamic Susceptibility-Weighted Contrast-Enhanced Magnetic Resonance Imaging Using Ferumoxytol vs. Gadoteridol: A Pilot Study

(2010) Seymur Gahramanov et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Magnetic resonance imaging of intracranial tumors: intra-patient comparison of gadoteridol and ferumoxytol

(2010) E. Dosa et al.   NEURO-ONCOLOGY

Ferumoxytol as an Intravenous Iron Replacement Therapy in Hemodialysis Patients

(2009) R. Provenzano et al.   Clinical Journal of the American Society of Nephrology

Safety of Ferumoxytol in Patients With Anemia and CKD

(2008) Ajay Singh et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Ferumoxytol for Treating Iron Deficiency Anemia in CKD

(2008) B. S. Spinowitz et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?

(2008) Edward A. Neuwelt et al.   KIDNEY INTERNATIONAL